Dr. Blackwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke Medical Ctr
# 3893
Durham, NC 27710Phone+1 919-668-1748Fax+1 919-681-0874
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1997 - 2000
- Duke University HospitalResidency, Internal Medicine, 1994 - 1997
- Mayo Clinic College of MedicineClass of 1994
Certifications & Licensure
- NC State Medical License 1995 - 2025
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer Start of enrollment: 2006 Apr 01
- A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain Start of enrollment: 2007 May 01
- Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1168 citationsRibociclib as First-Line Therapy for HR-Positive, Advanced Breast CancerGabriel N. Hortobagyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke
The New England Journal of Medicine. 2016-10-07 - 250 citationsUpdated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative a...G N Hortobagyi, S M Stemmer, H A Burris, Y S Yap, G S Sonke
Annals of Oncology. 2018-07-01 - 42 citationsDCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study.Oana Craciunescu, Kimberly L. Blackwell, Ellen L. Jones, James R. MacFall, Daohai Yu
International Journal of Hyperthermia. 2009-09-09
Press Mentions
- Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational UpdatesNovember 9th, 2022
- Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational UpdatesNovember 9th, 2022
- Tempus Announces Open Enrollment for Study in Collaboration with GSK to Evaluate Niraparib in Advanced Solid Tumor Patients with PALB2 MutationsJanuary 13th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: